Vanguard Group Inc Day One Biopharmaceuticals, Inc. Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 6,176,495 shares of DAWN stock, worth $46.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,176,495

Previous 5,943,243 3.92%

Holding current value

$46.1 Million

Previous $47.1 Million 14.81%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$6.16 - $7.97 $1.44 Million - $1.86 Million	233,252 Added 3.92%	6,176,495 $40.1 Million
Q1 2025 May 09, 2025	BUY	$7.93 - $13.21 $747,957 - $1.25 Million	94,320 Added 1.61%	5,943,243 $47.1 Million
Q4 2024 Feb 11, 2025	SELL	$12.46 - $16.39 $477,056 - $627,523	-38,287 Reduced 0.65%	5,848,923 $74.1 Million
Q3 2024 Nov 13, 2024	BUY	$12.72 - $16.03 $16.1 Million - $20.3 Million	1,263,938 Added 27.34%	5,887,210 $82 Million
Q2 2024 Aug 13, 2024	SELL	$12.03 - $17.69 $1.82 Million - $2.67 Million	-151,211 Reduced 3.17%	4,623,272 $63.7 Million
Q1 2024 May 10, 2024	BUY	$13.56 - $17.46 $64,233 - $82,708	4,737 Added 0.1%	4,774,483 $78.9 Million
Q4 2023 Feb 14, 2024	BUY	$9.68 - $15.37 $1.36 Million - $2.15 Million	139,992 Added 3.02%	4,769,746 $69.6 Million
Q3 2023 Nov 14, 2023	BUY	$11.22 - $14.86 $3.88 Million - $5.14 Million	346,090 Added 8.08%	4,629,754 $56.8 Million
Q2 2023 Aug 14, 2023	BUY	$11.74 - $14.47 $13.5 Million - $16.7 Million	1,151,683 Added 36.77%	4,283,664 $51.1 Million
Q1 2023 May 15, 2023	BUY	$12.75 - $23.41 $293,352 - $538,617	23,008 Added 0.74%	3,131,981 $41.9 Million
Q4 2022 Feb 10, 2023	BUY	$18.77 - $22.0 $9.26 Million - $10.9 Million	493,532 Added 18.87%	3,108,973 $66.9 Million
Q3 2022 Nov 14, 2022	SELL	$16.44 - $26.57 $181,382 - $293,146	-11,033 Reduced 0.42%	2,615,441 $52.4 Million
Q2 2022 Aug 12, 2022	SELL	$5.72 - $17.9 $2.06 Million - $6.44 Million	-359,952 Reduced 12.05%	2,626,474 $47 Million
Q1 2022 May 13, 2022	SELL	$9.12 - $17.47 $440,961 - $844,691	-48,351 Reduced 1.59%	2,986,426 $29.6 Million
Q4 2021 Feb 14, 2022	BUY	$15.65 - $26.33 $34.7 Million - $58.3 Million	2,214,704 Added 270.06%	3,034,777 $51.1 Million
Q3 2021 Nov 12, 2021	BUY	$20.0 - $27.92 $4.01 Million - $5.6 Million	200,689 Added 32.4%	820,073 $19.5 Million
Q2 2021 Aug 13, 2021	BUY	$19.0 - $23.69 $11.8 Million - $14.7 Million	619,384 New	619,384 $14.1 Million

Others Institutions Holding DAWN

# of Institutions

188

Shares Held

69.3M

Call Options Held

127K

Put Options Held

85.5K

View Full List

About Day One Biopharmaceuticals, Inc.

Ticker DAWN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,461,104
Market Cap $549M
Description
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...

More about DAWN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Day One Biopharmaceuticals, Inc. Transaction History